1- ( 2-amino-3- (substituted alkyl)-3H-benzimidazolylmethyl) - 3-substituted-1,3-dihydro-benzoimidazo l-2-ones with activity on respiratory syncytial virus
Details for Australian Patent Application No. 2006260969 (hide)
International Classifications
Event Publications
10 January 2008 PCT application entered the National Phase
PCT publication WO2006/136561 Priority application(s): WO2006/136561
22 July 2010 Amendment Made
The nature of the amendment is: Amend the invention title to read 1- ( 2-amino-3- (substituted alkyl)-3H-benzimidazolylmethyl) - 3-substituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus
17 November 2011 Application Accepted
Published as AU-B-2006260969
15 March 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006260970-Heterocyclylaminoalkyl substituted benzimidazoles
2006260961-Imidazolinone and hydantoine derivatives as novel inhibitors of histone deacetylase
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser
